Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


BOESS CARSTEN Create: Alert

All | News | Filings
Date FiledTypeDescription
06/17/2022 4 BOESS CARSTEN (Director) has filed a Form 4 on Avidity Biosciences, Inc.
Txns: Granted 22,000 options to buy @ $12.03, valued at $264.7k
06/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2021 4 BOESS CARSTEN (Director) has filed a Form 4 on Avidity Biosciences, Inc.
Txns: Granted 15,000 options to buy @ $26.09, valued at $391.4k
08/10/2020 3/A Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
08/03/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
06/18/2020 4 BOESS CARSTEN (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Granted 20,000 options to buy @ $19.9, valued at $398k
06/11/2020 3 BOESS CARSTEN (Director) has filed a Form 3 on Avidity Biosciences, Inc.
01/30/2019 4 BOESS CARSTEN (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Granted 30,000 options to buy @ $14.56, valued at $436.8k
05/29/2018 4 BOESS CARSTEN (10% Owner) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Converted 6,392 shares @ $0
Bought 6,392 options to buy @ $15.6438, valued at $100k
Converted 107,050 options to buy @ $0
Converted 6,392 options to buy @ $0
05/23/2018 3 BOESS CARSTEN (10% Owner) has filed a Form 3 on Kiniksa Pharmaceuticals, Ltd.
04/02/2018 4 BOESS CARSTEN (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Granted 40,000 options to buy @ $18.75, valued at $750k
06/21/2017 4 BOESS CARSTEN (Director) has filed a Form 4 on INOTEK PHARMACEUTICALS CORP
Txns: Granted 45,000 options to buy @ $1.8, valued at $81k
06/27/2016 4 BOESS CARSTEN (Director) has filed a Form 4 on INOTEK PHARMACEUTICALS CORP
Txns: Granted 12,000 options to buy @ $7.61, valued at $91.3k
01/12/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/23/2015 4 BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Disposed/sold 24,000 shares @ $0
Disposed/sold 9,929 options to buy @ $1.7, valued at $16.9k
Disposed/sold 7,292 options to buy @ $23, valued at $167.7k
Disposed/sold 45,000 options to buy @ $40.32, valued at $1.8M
Disposed/sold 15,938 options to buy @ $40.74, valued at $649.3k
Disposed/sold 40,000 options to buy @ $80.35, valued at $3.2M
06/09/2015 4 BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Granted 24,000 shares @ $0
02/19/2015 4 BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Sold 8,989 shares @ $98.85, valued at $888.6k
Sold 14,750 shares @ $99.97, valued at $1.5M
Sold 16,716 shares @ $100.74, valued at $1.7M
Sold 1,842 shares @ $101.69, valued at $187.3k
Exercised 13,235 options to buy @ $1.7, valued at $22.5k
Exercised 29,062 options to buy @ $40.74, valued at $1.2M
10/30/2014 4 BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Sold 1,500 shares @ $80, valued at $120k
Sold 1,000 shares @ $80, valued at $80k
Sold 22,904 shares @ $80.11, valued at $1.8M
Exercised 1,500 options to buy @ $1.7, valued at $2.6k
Exercised 1,000 options to buy @ $23, valued at $23k
Exercised 15,050 options to buy @ $1.7, valued at $25.6k
Exercised 7,854 options to buy @ $23, valued at $180.6k
06/05/2014 4 BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Granted 40,000 options to buy @ $80.35, valued at $3.2M
05/20/2014 4 BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Sold 8,136 shares @ $81.75, valued at $665.1k
Sold 1,591 shares @ $82.71, valued at $131.6k
Sold 200 shares @ $83.46, valued at $16.7k
Exercised 9,927 options to buy @ $1.7, valued at $16.9k
02/20/2014 4 BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Sold 1,000 shares @ $100.07, valued at $100.1k
Sold 3,081 shares @ $101.14, valued at $311.6k
Sold 3,207 shares @ $102.18, valued at $327.7k
Sold 1,745 shares @ $103.05, valued at $179.8k
Sold 894 shares @ $104.22, valued at $93.2k
Exercised 9,927 options to buy @ $1.7, valued at $16.9k
11/20/2013 4 BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Sold 3,861 shares @ $53.98, valued at $208.4k
Sold 1,765 shares @ $54.97, valued at $97k
Sold 3,801 shares @ $55.99, valued at $212.8k
Sold 500 shares @ $57.2, valued at $28.6k
Exercised 9,927 options to buy @ $1.7, valued at $16.9k
08/22/2013 4 BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Sold 7,800 shares @ $47.04, valued at $366.9k
Sold 6,681 shares @ $47.19, valued at $315.3k
Exercised 5,627 options to buy @ $1.7, valued at $9.6k
Exercised 2,173 options to buy @ $23, valued at $50k
Exercised 6,681 options to buy @ $23, valued at $153.7k
08/20/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
07/15/2013 4 BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Sold 13,237 shares @ $47.06, valued at $622.9k
Exercised 13,237 options to buy @ $1.7, valued at $22.5k
06/10/2013 4 BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Granted 45,000 options to buy @ $40.32, valued at $1.8M
10/18/2012 4 BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Sold 7,127 shares @ $49.88, valued at $355.5k
Sold 1,900 shares @ $50.58, valued at $96.1k
Sold 900 shares @ $51.17, valued at $46.1k
Exercised 9,927 options to buy @ $1.7, valued at $16.9k
07/20/2012 4 BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Sold 6,618 shares @ $48.82, valued at $323.1k
Exercised 6,618 options to buy @ $1.7, valued at $11.3k
06/29/2012 4 BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Granted 45,000 options to buy @ $40.74, valued at $1.8M
05/18/2012 4 BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Sold 28,137 shares @ $38.16, valued at $1.1M
Sold 11,572 shares @ $38.82, valued at $449.2k
Exercised 39,709 options to buy @ $1.7, valued at $67.5k
01/11/2012 4/A BOESS CARSTEN (CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Granted 25,000 options to buy @ $23, valued at $575k
12/22/2011 4 BOESS CARSTEN (CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Granted 25,000 options to buy @ $23, valued at $575k
11/10/2011 3 BOESS CARSTEN (CFO) has filed a Form 3 on SYNAGEVA BIOPHARMA CORP
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy